ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 827,27
-0,15%
DAX
18 557,27
-0,48%
Brent Oil
79,325
-0,69%
Bitcoin
69 345,84
-2,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Enanta Pharmaceuticals Inc (ENTA)

  7. Enanta Pharmaceuticals Inc (ENTA) Actualités

ENTA

Enanta Pharmaceuticals (ENTA)

Enanta Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ENTA
DateHeureSourceTitreSymboleSociété
29/05/202413h00Business WireEnanta Pharmaceuticals to Participate at the Jefferies Global Healthcare ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
08/05/202422h37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ENTAEnanta Pharmaceuticals Inc
08/05/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENTAEnanta Pharmaceuticals Inc
07/05/202413h00Business WireEnanta Pharmaceuticals to Participate at the JMP Securities Life Sciences ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
06/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENTAEnanta Pharmaceuticals Inc
06/05/202422h01Business WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ETNASDAQ:ENTAEnanta Pharmaceuticals Inc
30/04/202413h10Business WireEnanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
30/04/202413h00Business WireEnanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal OfficerNASDAQ:ENTAEnanta Pharmaceuticals Inc
29/04/202413h00Business WireEnanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024NASDAQ:ENTAEnanta Pharmaceuticals Inc
17/04/202413h00Business WireEnanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024NASDAQ:ENTAEnanta Pharmaceuticals Inc
08/03/202423h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
06/03/202413h00Business WireEnanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
27/02/202419h11Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ENTAEnanta Pharmaceuticals Inc
14/02/202420h26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ENTAEnanta Pharmaceuticals Inc
09/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENTAEnanta Pharmaceuticals Inc
07/02/202422h01Business WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ETNASDAQ:ENTAEnanta Pharmaceuticals Inc
06/02/202413h00Business WireEnanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
31/01/202413h00Business WireEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023NASDAQ:ENTAEnanta Pharmaceuticals Inc
26/01/202422h39Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ENTAEnanta Pharmaceuticals Inc
26/01/202422h37Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENTAEnanta Pharmaceuticals Inc
26/01/202422h25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ENTAEnanta Pharmaceuticals Inc
11/01/202422h15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ENTAEnanta Pharmaceuticals Inc
04/01/202413h00Business WireEnanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
03/01/202413h00Business WireEnanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
12/12/202323h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
22/11/202322h38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ENTAEnanta Pharmaceuticals Inc
22/11/202322h21Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ENTAEnanta Pharmaceuticals Inc
22/11/202322h12Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:ENTAEnanta Pharmaceuticals Inc
22/11/202313h00Business WireEnanta Pharmaceuticals to Participate at Evercore ISI HealthCONx ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
20/11/202322h01Business WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ETNASDAQ:ENTAEnanta Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ENTA

Dernières Valeurs Consultées

USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
EU
HO
Thales
EU
DG
Vinci
NASDAQ
AMZN
Amazon.com
EU
AI
Air Liquide
EU
PX4
SBF 120
NYSE
DIS
Walt Disney
EU
SGO
Cie de SaintGobain
EU
AF
Air FranceKLM
EU
RI
Pernod Ricard
FTSE
UKX
FTSE 100
EU
ACA
Credit Agricole
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés